Dr. Nadezda Gracheva

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Torqur AG Presents Interim Phase 2 Clinical Trial Results at American Academy of Dermatology

Spotlight on Leadership: Dr. Vladimir Cmiljanovic in The CEO Magazine